| AMARIN CORP.ADR NEW 2025 |
| USA |
| Gesundheit |
| US0231114044 / A41557 |
| EH3 (Frankfurt) / AMRN (NASDAQ) |
| FRA:EH3, ETR:EH3, EH3:GR, NASDAQ:AMRN |
| - |
| https://www.amarincorp.co.. |
|
Amarin Corporation plc is a biopharmaceutical comp..
>Volltext.. |
| 240.17 Mio. EUR |
| 0.53 Mio. EUR |
| 194.07 Mio. EUR |
| -51.86 Mio. EUR |
| -73.5 Mio. EUR |
| -3.56 EUR |
| 5.76 Mio. EUR |
| 105.3 Mio. EUR |
| -18.67 Mio. EUR |
| 1.57 |
| -6.31% |
| -116.72% |
| - |
| - |
| - |
| - |
| AMARIN |
| 09.01.26 |
|